Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hsu, Frank PK."'
Autor:
Torabi, Sina J., Nguyen, Theodore V., Bitner, Benjamin F., Du, Amy T., Warn, Michael, Chernyak, Michelle, Hsu, Frank PK., Kuan, Edward C.
Publikováno v:
In World Neurosurgery September 2024
Publikováno v:
Journal of Head and Neck Surgery. 2
Various cranial approaches exist to address lesions of the petrous apex. Many of these involve skull base approaches with varying degrees of surgical morbidity. We present a unique case of a recurrent petrous abscess that was treated with an endoscop
Autor:
Nguyen, Emely, Fu, Beverly, Dandekar, Manisha, Carrillo, Jose, Kong, Xiao-Tang, Cadena, Gilbert, Hsu, Frank PK, Billimek, John, Bota, Daniela
Publikováno v:
Neuro-oncology, vol 19, iss Suppl 6
Neuro-Oncology, vol 19, iss suppl_6
Neuro-Oncology, vol 19, iss suppl_6
Meningioma is the most common primary intracranial tumor in adults. Thorough majority of tumors are slow growing, many patients fail first-line treatments with surgery and/or radiation. Others are poor surgical candidates for definitive surgical rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::27a8e401be3dfb8c21e3d25664044aef
https://escholarship.org/uc/item/98b0w5w7
https://escholarship.org/uc/item/98b0w5w7
Autor:
Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos
Publikováno v:
CNS Oncology; July 2018, Vol. 7 Issue: 3
Publikováno v:
WIREs: Nanomedicine & Nanobiotechnology; May2014, Vol. 6 Issue 3, p245-267, 23p
Autor:
Thomas C. Chen, Jinah Chung, Jose Carrillo, Chrystel Pretto, Ankie Strik, Xiao-Tang Kong, Raphael Zidovetzki, Florence M. Hofman, Frank P.K. Hsu, Daniela A. Bota, Beverly Fu, Manisha Dandekar, Axel H. Schönthal, Apostolos Stathopoulos, Virgil E.J.C. Schijns
Publikováno v:
CNS oncology, 7(3), CNS22-CNS22
Bota, DA; Chung, J; Dandekar, M; Carrillo, JA; Kong, X-T; Fu, BD; et al.(2018). Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.. CNS oncology, 7(3), CNS22. doi: 10.2217/cns-2018-0009. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2rh7d5bm
CNS oncology 7 (2018) 3
CNS oncology, vol 7, iss 3
Bota, DA; Chung, J; Dandekar, M; Carrillo, JA; Kong, X-T; Fu, BD; et al.(2018). Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.. CNS oncology, 7(3), CNS22. doi: 10.2217/cns-2018-0009. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2rh7d5bm
CNS oncology 7 (2018) 3
CNS oncology, vol 7, iss 3
Author(s): Bota, Daniela A; Chung, Jinah; Dandekar, Manisha; Carrillo, Jose A; Kong, Xiao-Tang; Fu, Beverly D; Hsu, Frank Pk; Schonthal, Axel H; Hofman, Florence M; Chen, Thomas C; Zidovetzki, Raphael; Pretto, Chrystel; Strik, Ankie; Schijns, Virgil
Autor:
Annick Desjardins, Daniela A. Bota, Mohit Trikha, G. Kenneth Lloyd, Naomi Lomeli, Kaijun Di, Frank P.K. Hsu, Vivek Abraham, Francis Burrows
Publikováno v:
Bota, Daniela Annenelie; Hsu, Frank PK; Di, Kaijun; Abraham, Vivek; Lomeli, Naomi; Lloyd, G Kenneth; et al.(2015). Marizomib activity as a single agent in malignant gliomas: Ability to cross the blood brain barrier.. Journal of Clinical Oncology, 33(15_suppl), e12644-e12644. doi: 10.1200/jco.2015.33.15_suppl.e12644. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/9n94r1bx
e12644 Background: Glioblastoma (GBM) is a highly aggressive brain tumor which displays innate resistance to multiple treatment modalities. Previous studies have shown that the proteasome plays a v...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a240ce522cddc6173a7984a1773b7b
http://www.escholarship.org/uc/item/9n94r1bx
http://www.escholarship.org/uc/item/9n94r1bx
Publikováno v:
Hanson, Joseph A; Hsu, Frank PK; Jacob, Arun T; Bota, Daniela A; & Alexandru, Daniela. (2013). Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme.. The Permanente journal, 17(4), 68-74. doi: 10.7812/TPP/13-081. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/9db4b7s8
Despite aggressive investigation, glioblastoma multiforme (GBM) remains one of the deadliest cancers, with low progression-free survival and high one-year mortality. Current first-line therapy includes surgery with adjuvant radiation therapy and cyto
Autor:
Jiping Tang, Austin R. T. Colohan, Jan M. Eckermann, Vikram Jadhav, Wanqiu Chen, Frank P.K. Hsu, John H. Zhang
Publikováno v:
Medical Gas Research, Vol 1, Iss 1, p 7 (2011)
Medical Gas Research
Eckermann, Jan M; Chen, Wanqiu; Jadhav, Vikram; Hsu, Frank PK; Colohan, Austin RT; Tang, Jiping; et al.(2011). Hydrogen is Neuroprotective against Surgically Induced Brain Injury. Medical Gas Research, 1(1), 7. doi: http://dx.doi.org/10.1186/2045-9912-1-7. Retrieved from: http://www.escholarship.org/uc/item/9340g6xz
Medical Gas Research
Eckermann, Jan M; Chen, Wanqiu; Jadhav, Vikram; Hsu, Frank PK; Colohan, Austin RT; Tang, Jiping; et al.(2011). Hydrogen is Neuroprotective against Surgically Induced Brain Injury. Medical Gas Research, 1(1), 7. doi: http://dx.doi.org/10.1186/2045-9912-1-7. Retrieved from: http://www.escholarship.org/uc/item/9340g6xz
Background Neurosurgical operations cause unavoidable damage to healthy brain tissues. Direct surgical injury as well as surgically induced oxidative stress contributes to the subsequent formation of brain edema. Therefore, we tested the neuroprotect